Lv3
390 积分 2024-05-09 加入
Lysosome-targeting chimeras enable targeted protein degradation
3个月前
已完结
Biologic degraders push forward in the clinic
4个月前
已完结
Mechanistic Projection of First‐in‐Human Dose for Bispecific Immunomodulatory P‐Cadherin LP‐DART: An Integrated PK/PD Modeling Approach
4个月前
已完结
Mechanistic prediction of first-in-human dose for bispecific CD3/EpCAM T-cell engager antibody M701, using an integrated PK/PD modeling method
4个月前
已完结
Site-specific construction of triptolide-based antibody-drug conjugates
5个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
5个月前
已完结
皖公网安备34019202002308
